On March 25, 2022, I was invited to a Round Table organized by the distributors of my Formulation in Serbia.

This video from the conference is divided into two sections.

The first section (from the beginning to minute 7) outlines the history of my probiotic formulation. Bacteria as (or even better than) drugs? This was the fascinating and suggestive hypothesis that was read in the pages of the established British newspaper The Times referring to my invention. It was the year 2002 and this is the path that I have always followed by observing the strict criteria of clinical and experimental research.

Since those early days, my probiotic formulation has been clinically studied and used for the management of health conditions caused by dysbiosis (an imbalance in the body’s microbiome) including irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD) including ulcerative colitis (UC) and pouchitis, hepatic encephalopathy (HE), depression, autism, Alzheimer’s disease, pregnancy, and for babies born by Caesarean Section (C-section).

In the second section of the video (from min 7 to the end) I address some scientific and legal problems relating to the marketing of a badly copied product, propagated in a deceptive way and therefore sanctioned by the US Federal Court.